John Marioni elected to EMBO Membership

Senior Group Leader, Dr John Marioni, has been elected a member of the European Molecular Biology Organisation (EMBO) in recognition of his high-quality life science research.
Marioni is one of 64 life scientists that have been elected to EMBO membership this year, joining a community of more than 1,800 leading life scientists.
EMBO Members are actively involved in the organisation. They serve on EMBO Council, Committees, and Advisory Editorial Boards of EMBO Press journals, evaluate applications for EMBO funding, and mentor early-career scientists. Collectively, they can influence the direction of the life sciences in Europe and beyond.
“I am delighted to welcome the new members into our organisation and look forward to working with them,” says EMBO Director Maria Leptin. “An election to the EMBO Membership recognises outstanding achievements in the life sciences. The new members will provide expertise and guidance that will help EMBO to further strengthen its initiatives.”
New members are nominated and elected by the existing EMBO Membership; it is not possible to apply to become a member. One election is held each year. The new EMBO Members will be formally welcomed at the annual EMBO Members’ Meeting between 27 and 29 October 2021.
Related News
See all news-
Study looks at radiotherapy to treat and diagnose children’s brain tumours and avoid invasive surgery
3rd April 2025
A world first Cancer Research UK study is looking at radiotherapy to treat and diagnose children’s brain tumours and avoid invasive surgery.
Find out more -
Tony Davidge Shortlisted for National Papin Award for Outreach
31st March 2025
Tony’s nomination recognises his longstanding commitment to openness around the use of animals in cancer research, and the crucial role this openness plays in fostering understanding and trust.
Read more -
Sir Shankar Balasubramanian elected Fellow of the AACR Academy
10th March 2025
Sir Shankar has been recognised for his pioneering research in nucleic acid chemistry and his key role in the development of next-generation sequencing technology.
Find out more